| 000 | 01699 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518081716.0 | ||
| 264 | 0 | _c20201204 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a2588-9311 | ||
| 024 | 7 |
_a10.1016/j.euo.2019.12.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Bruijn, Roderick | |
| 245 | 0 | 0 |
_aDeferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. _h[electronic resource] |
| 260 |
_bEuropean urology oncology _c04 2020 |
||
| 300 |
_a168-173 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCytoreduction Surgical Procedures _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNephrectomy _xmethods |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xtherapeutic use |
| 700 | 1 | _aWimalasingham, Akhila | |
| 700 | 1 | _aSzabados, Bernadett | |
| 700 | 1 | _aStewart, Grant D | |
| 700 | 1 | _aWelsh, Sarah J | |
| 700 | 1 | _aKuusk, Teele | |
| 700 | 1 | _aBlank, Christian | |
| 700 | 1 | _aHaanen, John | |
| 700 | 1 | _aKlatte, Tobias | |
| 700 | 1 | _aStaehler, Michael | |
| 700 | 1 | _aPowles, Thomas | |
| 700 | 1 | _aBex, Axel | |
| 773 | 0 |
_tEuropean urology oncology _gvol. 3 _gno. 2 _gp. 168-173 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.euo.2019.12.004 _zAvailable from publisher's website |
| 999 |
_c30536512 _d30536512 |
||